ArticleFrontiers in public health2025
Global trends and future predictions of gastrointestinal ulcers in youth.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- A Comprehensive Analysis of Therapeutic Potential of Medicinal Plant Extracts to Treat Ethanol-Induced Gastric Ulcer.Biomedicines · 2026Review
- Mechanistic Insights into the Therapeutic Potential of Phytochemicals Against Stress-Induced Gastric Ulcer.Journal of inflammation research · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: By analyzing past disease trends and comparing two time series statistical models, we can predict the global burden of gastrointestinal ulcers in specific populations of adolescents and young adults aged 10-24. This prediction can provide important references for optimizing prevention and control strategies in healthcare systems. Methods: We collected data on prevalence, incidence, disability-adjusted life years (DALYs), and mortality for specific age groups between 10 and 24 years from 1990 to 2019. The data were then stratified by age, gender, and economic development level. We applied decomposition analysis and frontier analysis, and compared the performance of two statistical prediction models. We used the best-performing model to predict changes in each indicator. Results: In 2019, there were 958,842 (95% uncertainty interval [UI]: 639,698-1,371,106) prevalent cases, 407,850 (95% UI: 260,513-577,751) incident cases, 363,862 (95% UI: 309,793-422,230) DALY cases, and 4,404 (95% UI: 3,826-5,042) deaths globally, all showing an increasing trend compared to 1990. However, the age-standardized prevalence rate (ASPR), age-standardized incidence rate (ASIR), age-standardized DALY rate (ASDR), and age-standardized death rate (ASDER) all decreased from 1990 to 2019, with reductions of 6.6, 3.8, 50.86, and 53.8%, respectively. The estimated annual percentage change (EAPC) for these metrics was -0.59 (95% confidence interval [CI]: -0.73 to -0.46), -0.41 (95% CI: -0.51 to -0.31), -2.81 (95% CI: -2.96 to -2.66), and -3.1 (95% CI: -3.28 to -2.92), respectively. The ARIMA model, identified as the most accurate prediction model, suggests that by 2050, the burden of gastrointestinal ulcers in this age group will significantly decrease compared to 2019. Over the next 30 years, the global number of incident cases will initially rise before stabilizing, prevalent cases will fluctuate, and both DALYs and deaths will decline. ASPR, ASIR, ASDR, and ASDER will continue to decrease, with the most notable reductions in ASDR and ASDER. Conclusion: In 2019, the global burden of gastrointestinal ulcers showed significant increases in prevalent and incident cases, DALYs, and deaths compared to 1990. However, when adjusted for age, the prevalence rate (ASPR), incidence rate (ASIR), DALY rate (ASDR), and death rate (ASDER) all demonstrated substantial reductions, indicating improvements in management and prevention. The ARIMA model, identified as the most accurate, projects a significant decline in the burden of gastrointestinal ulcers for this age group by 2050, compared to 2019. While the raw numbers of cases and mortality have risen, age-standardized rates have decreased, reflecting advancements in healthcare strategies. These findings emphasize the need for continued focus on preventive measures and healthcare optimization to further reduce the global burden of gastrointestinal ulcers. The projected decline highlights the potential effectiveness of current strategies and offers a positive outlook for future management.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.